| T | Act | Project | Year | Sub | Principal Investigator(s)/ Project Leader(s) | Organization | Fiscal Year | Admin IC | Funding IC | FY Total Cost by IC | Similar Projects |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Development and Mechanistic Studies of an Engineered Human Enzyme to Abrogate Immune Suppression due to Elevated Methylthioadenosine (MTA) by MTAP null/low Tumors | |||||||||||
| 5Tf | R01Actf | CA240700Projectf | 02Yearf | UNIVERSITY OF TEXAS AT AUSTIN | 2020 | NCI | NCI | $377,573 | View View Similar Projects Similar Projectsf | ||
| T | Act | Project | Year | Sub | Principal Investigator(s)/ Project Leader(s) | Organization | Fiscal Year | Admin IC | Funding IC | FY Total Cost by IC | Similar Projects |
|---|